Carl Llor1, Josep Maria Cots. 1. Primary Care Center Jaume I, University Rovira i Virgili, Tarragona, Spain. carles.llor@urv.cat
Abstract
BACKGROUND: Current regulations in Spain state that antibiotics cannot be sold without a medical prescription. The objective of this study was to quantify the percentage of pharmacies selling antibiotics without an official medical prescription in Catalonia, Spain, by the simulation of 3 different clinical cases presented by actors. METHODS: A prospective study was performed from January through May 2008. Three different cases were presented at pharmacies: sore throat, acute bronchitis, and a urinary tract infection. Three levels of demand were used to convince the pharmacists to sell an antibiotic. RESULTS: A total of 197 pharmacies were visited. Antibiotics were obtained from 55 (79.7%) of 69 pharmacies when a urinary tract infection was simulated, 24 (34.8%) of 69 pharmacies when a sore throat was simulated, and 10 (16.9%) of 59 pharmacies when acute bronchitis was simulated (P < .001). Among the pharmacies that sold antibiotics, the pharmacists provided an explanation as to the number of times per day the drug should be taken in 84.3%, explained the duration of treatment in 68.7%, and inquired about allergies prior to the sale of the antibiotic in only 16.9%. Of the 108 pharmacies that did not sell the antibiotics, only 57 (52.8%) explained that they could not be given over the counter for health care reasons or to avoid antibiotic resistance. CONCLUSIONS: These results demonstrate that, although illegal, the sale of antibiotics without a prescription continues in Spain. This should be taken into account by countries that are currently considering the possibility of making some antibiotics available over the counter.
BACKGROUND: Current regulations in Spain state that antibiotics cannot be sold without a medical prescription. The objective of this study was to quantify the percentage of pharmacies selling antibiotics without an official medical prescription in Catalonia, Spain, by the simulation of 3 different clinical cases presented by actors. METHODS: A prospective study was performed from January through May 2008. Three different cases were presented at pharmacies: sore throat, acute bronchitis, and a urinary tract infection. Three levels of demand were used to convince the pharmacists to sell an antibiotic. RESULTS: A total of 197 pharmacies were visited. Antibiotics were obtained from 55 (79.7%) of 69 pharmacies when a urinary tract infection was simulated, 24 (34.8%) of 69 pharmacies when a sore throat was simulated, and 10 (16.9%) of 59 pharmacies when acute bronchitis was simulated (P < .001). Among the pharmacies that sold antibiotics, the pharmacists provided an explanation as to the number of times per day the drug should be taken in 84.3%, explained the duration of treatment in 68.7%, and inquired about allergies prior to the sale of the antibiotic in only 16.9%. Of the 108 pharmacies that did not sell the antibiotics, only 57 (52.8%) explained that they could not be given over the counter for health care reasons or to avoid antibiotic resistance. CONCLUSIONS: These results demonstrate that, although illegal, the sale of antibiotics without a prescription continues in Spain. This should be taken into account by countries that are currently considering the possibility of making some antibiotics available over the counter.
Authors: Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg Journal: Lancet Infect Dis Date: 2011-06-12 Impact factor: 25.071
Authors: Sara Elizabeth Boyd; Luke Stephen Prockter Moore; Mark Gilchrist; Ceire Costelloe; Enrique Castro-Sánchez; Bryony Dean Franklin; Alison Helen Holmes Journal: J Antimicrob Chemother Date: 2017-05-01 Impact factor: 5.790
Authors: Antonio Hernández; Pilar Garcia-Delgado; Victoria Garcia-Cardenas; Ana Ocaña; Elena Labrador; Maria Luisa Orera; Fernando Martinez-Martinez Journal: Int J Clin Pharm Date: 2015-02-24
Authors: Sara Malo; Lars Bjerrum; Cristina Feja; María Jesús Lallana; José María Abad; María José Rabanaque-Hernández Journal: Eur J Clin Pharmacol Date: 2013-12-10 Impact factor: 2.953